Close Menu

NEW YORK — Lab Genomics has signed a distribution agreement to offer Contextual Genomics' Follow It next-generation sequencing-based cancer genomic assay in Southern California and certain other parts of the US, the companies announced on Monday.

Specific terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.